Dive Into Other Topics

Oct 25, 2023

Insulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.

Oct 23, 2023

Following two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.

Oct 20, 2023

On October 13 2023, the FDA has granted approval for Pfizer’s ulcerative colitis treatment, Etrasimod, under the brand name Velsipity.

Oct 18, 2023

Allergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...

Oct 16, 2023

Rare eye diseases can pose burden on patients. Top rare eye diseases are Stargardt Disease, Retinitis Pigmentosa, LHON, Retinoblastoma, LSCD

Oct 13, 2023

On September 29, 2023, FDA approved EXXUA, the ER gepirone hydrochloride tablets by Fabre-Kramer, for major depressive disorder treatment.

Oct 11, 2023

Immunomodulators are reshaping the healthcare market outlook with their diverse benefits and applications, thereby improving health outcomes.

Oct 09, 2023

FDA approved Rivfloza for primary hyperoxaluria treatment. This announcement comes as Novo continues to make strides in field of RNAi drugs.

Oct 06, 2023

Since scopolamine transdermal patch FDA approval, no other treatments approved in US for nausea and vomiting induced by motion sickness.

Oct 04, 2023

Alzheimer’s Disease represents one of the most pressing challenges in today's healthcare market. As its prevalence continues to soar with the aging global population, the hurdles in its diagnostic and treatment also continue to rise. As per the estimate, globally, about 55 million people are living with dementia in...